Literature DB >> 21064161

Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles.

BeiBei Luo1, Jayanthi Repalli, Al-Motassem Yousef, Saphronia R Johnson, Lukasz Lebioda, Sondra H Berger.   

Abstract

Thymidylate synthase (TS) is a well-validated cancer target that undergoes conformational switching between active and inactive states. Two mutant human TS (hTS) proteins are predicted from crystal structures to be stabilized in an inactive conformation to differing extents, with M190K populating the inactive conformation to a greater extent than A191K. Studies of intrinsic fluorescence and circular dichroism revealed that the structures of the mutants differ from those of hTS. Inclusion of the substrate dUMP was without effect on M190K but induced structural changes in A191K that are unique, relative to hTS. The effect of strong stabilization in an inactive conformation on protein phosphorylation by casein kinase 2 (CK2) was investigated. M190K was highly phosphorylated by CK2 relative to an active-stabilized mutant, R163K hTS. dUMP had no detectable effect on phosphorylation of M190K; however, dUMP inhibited phosphorylation of hTS and R163K. Studies of temperature dependence of catalysis revealed that the E(act) and temperature optimum are higher for A191K than hTS. The potency of the active-site inhibitor, raltitrexed, was lower for A191K than hTS. The response of A191K to the allosteric inhibitor, propylene diphosphonate (PDPA) was concentration dependent. Mixed inhibition was observed at low concentrations; at higher concentrations, A191K exhibited nonhyperbolic behavior with respect to dUMP and inhibition of catalysis was reversed by substrate saturation. In summary, inactive-stabilized mutants differ from hTS in thermal stability and response to substrates and PDPA. Importantly, phosphorylation of hTS by CK2 is selective for the inactive conformation, providing the first indication of physiological relevance for conformational switching.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21064161      PMCID: PMC3047064          DOI: 10.1002/pro.539

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data.

Authors:  Lee Whitmore; B A Wallace
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine.

Authors:  M M Davies; P G Johnston; S Kaur; T G Allen-Mersh
Journal:  Clin Cancer Res       Date:  1999-02       Impact factor: 12.531

3.  A structural role for glutamine 214 in human thymidylate synthase.

Authors:  D J Steadman; P S Zhao; H T Spencer; R B Dunlap; S H Berger
Journal:  Biochemistry       Date:  1998-05-19       Impact factor: 3.162

4.  A hydroxyl group at residue 216 is essential for catalysis by human thymidylate synthase.

Authors:  A W Williams; R B Dunlap; S H Berger
Journal:  Biochemistry       Date:  1998-05-19       Impact factor: 3.162

5.  Functional role of cysteine-146 in Escherichia coli thymidylate synthase.

Authors:  I K Dev; B B Yates; J Leong; W S Dallas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Mode of binding of folate analogs to thymidylate synthase. Evidence for two asymmetric but interactive substrate binding sites.

Authors:  I K Dev; W S Dallas; R Ferone; M Hanlon; D D McKee; B B Yates
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

7.  Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

Authors:  E Chu; D M Koeller; J L Casey; J C Drake; B A Chabner; P C Elwood; S Zinn; C J Allegra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 8.  The catalytic mechanism and structure of thymidylate synthase.

Authors:  C W Carreras; D V Santi
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

9.  ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.

Authors:  A L Jackman; G A Taylor; W Gibson; R Kimbell; M Brown; A H Calvert; I R Judson; L R Hughes
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

10.  Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.

Authors:  P G Johnston; H J Lenz; C G Leichman; K D Danenberg; C J Allegra; P V Danenberg; L Leichman
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

View more
  9 in total

1.  Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.

Authors:  Hitesh Sharma; Mark J Landau; Todd J Sullivan; Vidya P Kumar; Markus K Dahlgren; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2013-12-31       Impact factor: 2.823

2.  Evolution of metamorphism in thymidylate synthases within the primate lineages.

Authors:  BeiBei Luo; Saphronia R Johnson; Lukasz Lebioda; Sondra H Berger
Journal:  J Mol Evol       Date:  2011-02-12       Impact factor: 2.395

3.  Crystal structure of the active form of native human thymidylate synthase in the absence of bound substrates.

Authors:  P Deschamps; S Réty; J Bareille; N Leulliot
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-05-25       Impact factor: 1.056

4.  Selective peptide inhibitors of bifunctional thymidylate synthase-dihydrofolate reductase from Toxoplasma gondii provide insights into domain-domain communication and allosteric regulation.

Authors:  Mark J Landau; Hitesh Sharma; Karen S Anderson
Journal:  Protein Sci       Date:  2013-08-01       Impact factor: 6.725

5.  Analysis of mRNA recognition by human thymidylate synthase.

Authors:  Nicholas D Brunn; Sergey M Dibrov; Melody B Kao; Majid Ghassemian; Thomas Hermann
Journal:  Biosci Rep       Date:  2014-12-23       Impact factor: 3.840

6.  Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.

Authors:  Hala O El-Mesallamy; Hekmat M El Magdoub; James M Chapman; Nadia M Hamdy; Mona F Schaalan; Lamiaa N Hammad; Sondra H Berger
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

7.  Inhibition of Protein Kinase CK2 Affects Thymidylate Synthesis Cycle Enzyme Level and Distribution in Human Cancer Cells.

Authors:  Patrycja Wińska; Łukasz Widło; Elżbieta Senkara; Mirosława Koronkiewicz; Jarosław M Cieśla; Alicja Krzyśko; Katarzyna Skierka; Joanna Cieśla
Journal:  Front Mol Biosci       Date:  2022-02-25

8.  Dynamic allostery in substrate binding by human thymidylate synthase.

Authors:  Jeffrey P Bonin; Paul J Sapienza; Andrew L Lee
Journal:  Elife       Date:  2022-10-06       Impact factor: 8.713

9.  Non-covalent interactions involving halogenated derivatives of capecitabine and thymidylate synthase: a computational approach.

Authors:  Adhip Rahman; Mohammad Mazharol Hoque; Mohammad A K Khan; Mohammed G Sarwar; Mohammad A Halim
Journal:  Springerplus       Date:  2016-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.